Objectives: To identify a novel putative lincosamide resistance gene determinant in a swine Enterococcus faecalis E531 exhibiting a lincosamide resistance/macrolide susceptibility (L R M S ) phenotype and to determine its location and genetic environment.
Introduction
Lincosamides, including lincomycin, clindamycin and pirlimycin, are active against many Gram-positive cocci (Staphylococcus, Streptococcus and Enterococcus) and anaerobes (Bacteroides and Clostridium), and therefore play an important role in both human and veterinary medicine. 1, 2 In veterinary practice, lincomycin alone or in combination with spectinomycin are widely used for the control of a number of bacterial pathogens involved in respiratory and gastrointestinal infection in cattle, swine, poultry, dogs and cats, with pirlimycin only in the bovine mastitis cases. 3 However, clindamycin is not only widely used in human medicine, but also for the treatment of topical infection in dogs and cats. 4 Lincosamides prevent protein synthesis by inhibiting the peptidyltransferase activity in binding mainly the A2058 of the 23S rRNA in the 50S subunit of the bacterial ribosome. 5 Resistance to lincosamides is mainly divided into two categories. First, modification of the intracellular target of the antibiotics by N 6 dimethylation of adenine in 23S rRNA, which confers crossresistance to macrolide, lincosamide and streptogramin B antibiotics (MLS B phenotype). This alteration of the antibiotic target site is catalysed by an rRNA methyltransferase encoded by erm genes. 6 Secondly, enzymatic inactivation of lincosamides by nucleotidylation via O-nucleotidyltransferase, which only confers the specific resistance to lincosamides (L phenotype). 7 Since the first report of a lincosamide nucleotidyltransferase lnu(A) (formerly linA), 8 a number of lnu genes have been described in various bacteria of human or animal origin (http://faculty.washington.edu/ marilynr/), including lnu(B), 9 lnu(C), 10 lnu(D), 11 lnu(E), 12 lnu(F) and lnu(P), 13, 14 with most of them located on the plasmids or transposons. 8, 9, 14 In the present study, a novel putative lincosamide nucleotidyltransferase gene was identified in a swine Enterococcus faecalis strain exhibiting an L R M S phenotype. In addition, its location and genetic environment were explored. Figure Zhu et al.
Materials and methods

Bacterial strains and plasmids
E. faecalis E531 exhibiting an L R /M S phenotype, which tested negative for the known lincosamide nucleotidyltransferase genes [lnu(A)-lnu(F) and lnu(P)], was used for the sequencing and analysis. It was identified and stored in our lab in a routine survey of lincomycin-resistant enterococci of swine origin in Henan province, China. E. faecalis JH2-2 (Rif r ) was used as the recipient strain in the transformation experiment. The Escherichia coli-E. faecalis shuttle plasmid pAM401 (ATCC 37429) was used in the cloning experiment.
DNA sequencing and analysis
The whole genomic DNA of E. faecalis E531 was sequenced (Illumina HiSeq 2500; Beijing Novogene Bioinformatics Technology Co., Ltd, China). Sequence comparison and assembly were performed using the BLAST procedure (http://blast.ncbi.nlm.nih.gov) and DNAStar software (Lasergene, Madison, WI, USA), respectively. Multiple sequence alignment and phylogenetic tree construction were performed by using DNAMAN software (Lynnon-BioSoft, Ontario, Canada).
Cloning of a putative lincosamide resistance determinant
A 1577 bp fragment containing BamHI and XbaI restriction sites in the noncoding regions at the 5' and 3' termini of the lnu(G) gene was amplified by PCR using a pair of primers lnu(G)-fw/lnu(G)-rv listed in Table S1 (available as Supplementary data at JAC Online). Then the amplified fragment was ligated into the BamHI-and XbaI-digested E. coli-E. faecalis shuttle vector pAM401. The recombinant plasmid pAM401-lnu(G) was then transformed into E. faecalis JH2-2 by electroporation (MicroPulser; Bio-Rad, USA) and the transformants were selected on medium containing lincomycin (20 mg/L) and chloramphenicol (10 mg/L).
Antimicrobial susceptibility testing
The MICs were determined using the broth microdilution method following the recommendations as described by CLSI. 15 The reference strain Staphylococcus aureus ATCC 29213 served as the quality control strain.
Lincomycin inactivation
The lincomycin inactivation assay was performed in liquid medium by UPLC-MS/MS (Waters, Milford, MA, USA) as previously described and modified as follows. 12 The E. faecalis WT E531, JH2-2 ! pAM401-lnu(G) and E. faecalis JH2-2 ! pAM401 (control sample) were included in this study.
Genetic environment analysis
Based on the assembled sequence DtnpB-tnpC-lnu(G) derived from the sequenced contig, first, two overlapping PCRs were performed using primers I-fw/I-rv and II-fw/II-rv (Table S1 , available as Supplementary data at JAC Online) to confirm the correctness of the assembled sequence. Then, to map further the genetic context of the lnu(G) gene, an inverse PCR of the genomic DNA after digestion by HindIII and following self-ligation with T4 DNA ligase was performed using the primers III-fw/ III-rv (Table S1 , available as Supplementary data at JAC Online). Sequencing of amplicons was performed by primer walking. Sequence analysis and annotation were performed using BLAST procedure (http:// blast.ncbi.nlm.nih.gov) and DNAStar software (Lasergene, Madison, WI, USA). To detect whether a putative transposon containing the lnu(G) gene is active, a circular intermediate was detected using an inverse PCR following the primers circ-fw/circ-rv (Table S1 , available as Supplementary data at JAC Online).
Nucleotide sequence accession number
The sequence determined in this study has been deposited in GenBank under accession number KX470419.
Results and discussion
The lnu(G) gene encodes a putative lincosamide nucleotidyltransferase
Sequencing analysis revealed that an 804 bp ORF encoding a 267 amino acid (aa) protein was identified in E. faecalis E531, which showed 76.0% identity to the lincosamide nucleotidyltransferase Lnu(B) in Enterococcus faecium (GenBank accession no. AF110130). 9 As an amino acid identity of 79.0% is considered indicative of a novel type of Lnu protein, the designations lnu(G) and Novel lnu(G) gene in E. faecalis JAC Lnu(G) were tentatively provided by the nomenclature centre for MLS resistance genes (http://faculty.washington.edu/marilynr/) for the new gene and the corresponding protein, respectively. A homology tree of the Lnu(G) protein with other lincosamide nucleotidyltransferases deposited in the GenBank database is shown in Figure S1 (available as Supplementary data at JAC Online). Lnu(G) was closely related to Lnu(B), and also exhibited a low identity of 34.1% to Lnu(F) from E. coli (GenBank accession no. AJ561197). No significant homology was found between Lnu(G) in E. faecalis (GenBank accession no. KX470419) and Lnu(A) from Staphylococcus haemolyticus (GenBank accession no. M14039.1), Lnu(C) from Streptococcus agalactiae (GenBank accession no. AY928180), Lnu(D) from Streptococcus uberis (GenBank accession no. EF452177), Lnu(E) from Streptococcus suis (GenBank accession no. KF287643) or Lnu(P) from Clostridium perfringens (GenBank accession no. FJ589781), respectively.
The lnu(G) gene conferred the resistance to lincomycin by nucleotidylation
Antimicrobial susceptibility testing revealed that both E. faecalis WT E531 and JH2-2 ! pAM401-lnu(G) exhibited a 4-fold increase in the MIC of lincomycin (32 mg/L), but susceptibility to clindamycin (2 mg/L) and pirlimycin (0.5 mg/L), compared with E. faecalis JH2-2 or E. faecalis JH2-2 ! pAM401 only (Table S2 , available as Supplementary data at JAC Online). Moreover, no MIC changes were observed for erythromycin, gentamicin, vancomycin, ampicillin, ciprofloxacin, linezolid, tetracycline, chloramphenicol and florfenicol (data not shown).
To confirm the mechanism of resistance conferred by the lnu(G) gene, E. faecalis WT E531, JH2-2 ! pAM401-lnu(G) and E. faecalis JH2-2 ! pAM401 cells were tested for their ability to inactivate lincomycin. UPLC-MS/MS analysis showed that the E. faecalis WT E531 revealed a major peak eluted at 1.79 min ( Figure  1a) , with E. faecalis JH2-2 ! pAM401-lnu(G) at 1.75 min (Figure 1c) , whereas no chromatographic peak emerged in the control sample (Figure 1b) . The MS spectra showed presence of the non-modified lincomycin (m/z 407.8 Da) in the control sample (Figure 1d ). The inactivated materials were shown to have a mass of 736.8 Da for lincomycin in both E. faecalis WT E531 (Figure 1e ) and E. faecalis JH2-2 ! pAM401-lnu(G) (data not shown), which was 329 Da heavier than the original lincomycin. Other fragments of 719.2, 601.8 and 469.9 Da were believed to result from leakage of the adenine moiety or the adenosine moiety of the compound, respectively, as previously described in the inactivation of lincomycin by Lnu(C), 10 Lnu(D) or Lnu(E). 11, 12 These results suggest that the inactivation products are adenylated lincomycin as previously described and confirm that the Lnu(G) protein is a novel type of lincosamide nucleotidyltransferase. [9] [10] [11] [12] In this study, Lnu(G) only increased the MICs of lincomycin, but not those of clindamycin and pirlimycin. The reason could be hypothetically explained by differences in the affinity of lincosamides for either the nucleotidyltransferase or the host ribosome. 9 Therefore, further studies about the structure determination and substrate specificity of the Lnu(G) protein will be needed to elucidate this phenomenon.
The lnu(G) gene was embedded into a novel active transposon Tn6260, belonging to the Tn554 family Through two overlapping PCRs and an inverse PCR, a 5706 bp HindIII fragment containing the lnu(G) gene was obtained. As shown in Figure 2 , the genetic environment analysis revealed that the lnu(G) gene was embedded into a novel 4738 bp transposon, designated Tn6260 (provided by Dr Adam Roberts, http://www.ucl.ac.uk/eastman/research/departments/microbialdiseases/tn). The presence of 1641 bp circular Tn6260 forms indicated that this transposon was active in the E. faecalis strain E531. Comparisons with the reported Tn554 family transposons in the transposase genes tnpA, tnpB and tnpC and corresponding proteins showed that the transposon Tn6260 fell into this family (Table S3 , available as Supplementary data at JAC Online). [16] [17] [18] [19] [20] They shared a similar structure in the transposase genes, but differed distinctly in the resistance gene regions, such as spc and erm(A) in S. aureus Tn554, 20 fexA in Staphylococcus lentus Tn558, 17 dfrK in S. aureus Tn559, 18 vga(A) variant in S. aureus Tn5406 19 and lnu(G) in E. faecalis Tn6260 in this study.
Conclusions
A novel chromosome-borne lincosamide nucleotidyltransferase gene lnu(G) was identified in a swine E. faecalis strain, which conferred resistance to lincomycin by nucleotidylation. The presence of the lnu(G) gene within a functionally active transposon will accelerate its dissemination. Whether the lnu(G) gene is also located on plasmids and how prevalent it is in enterococci or other Grampositive organisms of human and veterinary significance need to be further elucidated.
